Kenon Holdings Ltd.

Kenon reported Q1 2018 net income of $552 million versus a net loss of $10 million in Q1 2017. The company said it recognized a $567 million gain in the quarter related to the Qoros third-party investment, including $504 million from dilution, the put option, and shareholder loan items, plus a $63 million write-back of financial guarantee. OPC reported EBITDA of $35 million, up from $28 million in Q1 2017, and management said its revenue and net income were also higher, helped mainly by currency translation effects. On liquidity, Kenon said it had $55 million of unconsolidated cash and no debt, plus about $248 million held at Quantum, for total cash of approximately $303 million. For Qoros, management said the company had received RMB1.69 billion, or about $270 million, to date from the third-party investment, and roughly $95 million would remain with Kenon after planned reinvestment and loan repayment; no next-quarter or full-year financial guidance was provided.

Barak Cohen framed the quarter around Kenon’s strategy of realizing value for shareholders, pointing to the Qoros transaction as a significant step and OPC’s strong quarter as further evidence of execution. He emphasized that Kenon remains committed to monetizing value from its businesses rather than providing broad operating guidance. His tone was positive and transactional, focused on progress already achieved and the next steps in the Qoros process.

Mark Hasson focused on the accounting and balance-sheet impact of the quarter. He said Kenon booked a $567 million Qoros-related gain and a $63 million write-back of financial guarantee, which together drove the $552 million net income result, and he reiterated that Kenon has no debt. He also highlighted liquidity of about $303 million in total cash, consisting of $55 million unconsolidated cash and roughly $248 million at Quantum pending completion of the Qoros transaction, plus the $175 million deferred payment from the Inkia sale that accrues interest at 8% per year.

There was essentially no analyst Q&A in the transcript; the call ended after management’s prepared remarks and a brief closing from Robert Rosen. The most notable management commentary centered on the Qoros capital increase approval process, the expected use of proceeds, and the possibility that Kenon could later call the new Qoros investors to buy the remaining equity. Management also noted Qoros sales growth, including that first-quarter sales included orders from a leasing company introduced by the new investor.